New research makes first broad-spectrum antiviral

Scientists at the Advanced Science Research Center at the CUNY Graduate Center target the viral envelop to fight multiple viruses

2025-08-27

(Press-News.org) NEW YORK, August 27, 2025 — Researchers at the Nanoscience Initiative at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) have made a breakthrough in the fight against viral diseases. Their study, published in the journal Science Advances, offers a promising path toward the development of the world’s first broad-spectrum antiviral (BSA), which could be deployed against a wide range of deadly viruses, including future pandemic threats.

Unlike bacterial infections, which doctors often begin immediately treating with broad-spectrum antibiotics while they work to determine the specific bacteria, viral infections are treated with antivirals, which are narrowly targeted and effective against only a small set of related viruses.

“This lack of treatments can leave populations vulnerable for years, while vaccines and therapeutics are being developed,” said Principal Investigator Adam Braunschweig, a Nanoscience Initiative professor at CUNY ASRC and a Chemistry and Biochemistry professor at Hunter College.

Braunschweig’s team set out to address this global health challenge by targeting a shared feature found on the surface of many viruses: viral envelope glycans—sugar molecules that are structurally conserved across unrelated viral families. These widely shared have until now remained an untapped target for antiviral drug development.

The researchers screened 57 synthetic carbohydrate receptors (SCRs), which are small molecules designed to bind to viral glycans. They identified four lead compounds that successfully blocked infection from seven different viruses across five unrelated families, including some of the world’s most dangerous pathogens: Ebola, Marburg, Nipah, Hendra, SARS-CoV-1, and SARS-CoV-2.

In a critical test, one of the lead SCR compounds was used to treat mice infected with SARS-CoV-2. Ninety percent of the mice receiving the SCR survived, compared to none in the control group. Further analysis confirmed that the compounds work by binding to viral envelope glycans—a novel mechanism of action with potential applications not only for infectious diseases but also for cancer and immune disorders.

“This is the kind of antiviral tool the world urgently needs,” said Braunschweig. “If a new virus emerges tomorrow, we currently have nothing to deploy. These compounds offer the potential to be that first line of defense.”

The next phase of the team’s research will focus on advancing the most promising compounds into clinical trials.

This work was supported by the Army Research Office, National Institutes of Health, New York State Biodefense Commercialization Fund, Air Force Office of Scientific Research, and the COVID-19 High Performance Computing Consortium.

About the Graduate Center of The City University of New York
The CUNY Graduate Center is a leader in public graduate education devoted to enhancing the public good through pioneering research, serious learning, and reasoned debate. The Graduate Center offers ambitious students nearly 50 doctoral and master’s programs of the highest caliber, taught by top faculty from throughout CUNY — the nation’s largest urban public university. Through its nearly 40 centers, institutes, initiatives, and the Advanced Science Research Center, the Graduate Center influences public policy and discourse and shapes innovation. The Graduate Center’s extensive public programs make it a home for culture and conversation.

About the Advanced Science Research Center at the CUNY Graduate Center
The Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) is a world-leading center of scientific excellence that elevates STEM inquiry and education at CUNY and beyond. The CUNY ASRC’s research initiatives span five distinctive, but broadly interconnected disciplines: nanoscience, photonics, neuroscience, structural biology, and environmental sciences. The center promotes a collaborative, interdisciplinary research culture where renowned and emerging scientists advance their discoveries using state-of-the-art equipment and cutting-edge core facilities.

END

ELSE PRESS RELEASES FROM THIS DATE:

Good sleep quality might be key for better mental wellbeing in young adults

2025-08-27

A new study of young adults has strongly linked better sleep quality with better mental wellbeing, with fruit and vegetable consumption and physical activity also strongly associated with psychological wellbeing. Perhaps surprisingly, the findings also suggest that boosting fruit and vegetable intake could potentially help mitigate the effects on wellbeing of a poor night’s sleep. Dr. Jack Cooper, previously from the University of Otago, New Zealand, and colleagues present these findings in the open-access journal PLOS One on August 27, 2025. Prior research ...

One step closer to improving ER+ breast cancer patients’ response to therapy

2025-08-27

A new study from researchers at Baylor College of Medicine brings hope for a more personalized approach to treat estrogen receptor-positive (ER+) breast cancer, the most common type of this cancer. The team identified a biomarker in preclinical ER+ breast cancer models that indicates that the tumor is more likely to respond to treatment with CDK4/6 inhibitors. The findings support further clinical studies to determine whether this marker may help identify patients who could benefit from CDK4/6 inhibitors. The study appeared in Science Translational Medicine. ER+ breast ...

Scientists reveal the first structure of the complete botulinum neurotoxin complex

2025-08-27

Researchers at Stockholm University have succeeded in creating a molecular blueprint of how one of the world's most dangerous toxins, botulinum toxin, is structured, stabilised, delivered and released. The research, published in the scientific journal Science Advances, paves the way for more effective drugs. Botulinum toxin is the strongest poison known to man – a million times more toxic than that found in cobra venom. The toxin is produced by the bacterium Clostridium botulinum. The toxin causes the serious illness botulism. However, the toxin also has many medical uses, for treating chronic migraine, ...

Children’s Hospital of Philadelphia researchers link dietary fats to more severe form of asthma

2025-08-27

Philadelphia, August 27, 2025 – Researchers at Children’s Hospital of Philadelphia (CHOP) found that certain lipids, or fats, in obesity-causing foods also cause asthma-like lung inflammation. The findings suggest that in addition to modifying dietary choices, certain existing drugs could be repurposed to help treat this type of asthma. The findings were published online today by the journal Science Translational Medicine. The study was prompted by researchers noticing an association between childhood obesity and neutrophilic asthma, a non-allergic type of asthma triggered ...

Rising temperatures intensify "supercell thunderstorms" in Europe

2025-08-27

Supercell thunderstorms are among the most impactful weather events in Europe. They typically occur in summer and are characterized by a rotating updraft of warm, humid air that brings strong winds, large hail and heavy rain. The impact is significant and often leads to property damage, agricultural losses, traffic chaos and even threats to human safety. The collaboration between the Institute of Geography, the Oeschger Center for Climate Change Research and the Mobiliar Lab for Natural Risks at the University of Bern and the Institute for Atmospheric and Climate ...

New Hebrew SeniorLife affordable senior housing building achieves Phius Certification

2025-08-27

Hebrew SeniorLife, a Harvard Medical School–affiliated nonprofit organization dedicated to improving the lives of older adults, has announced that its 108 Centre Street affordable senior housing building, located on the Center Communities of Brookline campus, has officially received Phius Certification for its high-performance, energy-efficient design. The seven-story, all-electric multifamily building provides 54 affordable apartments for seniors and significantly advances sustainable, healthy housing for older adults in Greater Boston. “Achieving Phius Certification reinforces our commitment not only to affordability and community, but also to environmental responsibility ...

Overworked brain cells may burn out in Parkinson’s disease

2025-08-27

SAN FRANCISCO—Certain brain cells are responsible for coordinating smooth, controlled movements of the body. But when those cells are constantly overactivated for weeks on end, they degenerate and ultimately die. This new observation made by scientists at Gladstone Institutes may help explain what goes awry in the brains of people with Parkinson’s disease. Researchers have long known that a particular subset of neurons die as Parkinson’s disease progresses, but they aren’t sure why. The new work, published in the scientific journal eLife, shows that in mice, chronic activation of these neurons can directly cause their demise. The scientists hypothesize ...

One in seven bariatric surgery patients turn to new weight loss drugs

2025-08-27

Bariatric surgery is usually effective on its own for weight loss, but an increasing proportion of patients who undergo bariatric surgery start taking one of the new glucagon-like 1 peptide receptor agonist (GLP-1) weight-loss drugs in the years after their surgery, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health. The researchers analyzed de-identified national electronic health records covering 112,858 individuals who underwent bariatric surgery from January 2015 to May 2023. They found that 14% of those patients used a GLP-1 such ...

A nonsurgical path to treating pelvic organ prolapse

2025-08-27

Pelvic organ prolapse (POP) is a disorder that primarily affects older women who have experienced multiple vaginal childbirths. Repeated vaginal deliveries can cause the muscles and connective tissue that hold the pelvic organs—the vagina, bladder, uterus, urethra, and rectum—to weaken, causing one or more of the organs to drop out of position and bulge or extrude outside the body. “There’s a breakdown and loss of the elastic matrix which contributes to tissue elasticity, similar to how a rubber band can stretch and recoil,” says Lehigh University ...

Electrons reveal their handedness in attosecond flashes

2025-08-27

We have all been familiar since childhood with the fact that our left and right hands are identical in structure but not in shape. They are mirror images of each other. In everyday life, this means that a left-handed glove does not fit on the right hand. This “handedness” is also a fundamental property of matter: similar to our hands, many molecules exist in two mirror-image versions, which, despite looking confusingly similar, are actually not identical. Chemists call this chirality. The distinction between right- and left-handed chiral molecules ...

New research makes first broad-spectrum antiviral

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: